Delivery Order SPE2DB24D2205-SPE2DB25FEGTH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $53,327.86 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen prefilled syringes. This firm fixed-price, competitively awarded contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating open competition among...
- The Defense Logistics Agency awarded a $52,711.33 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of SKYRIZI 150 mg/mL pen injections, with final delivery required by August 28, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across the Defense Health...
- The Defense Logistics Agency awarded a $14,917.68 delivery order (Contract No. 4569133354) to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. Performance is scheduled to be completed by August 19, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $59,150 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger indefinite delivery contract vehicle, this award represents a tactical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of SKYRIZI 150 mg/ml in pen/ml formulation, with a ceiling value of $24,342.14. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order contract valued at $34,595.45 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injections on September 16, 2025. The contract utilizes a firm fixed price delivery order structure with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This order falls under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product, with a ceiling value of $26,166.64. This competitively awarded, firm fixed-price delivery order is set to conclude on August 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $38,911.60 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed price, non-set-aside contract will be completed by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of SKYRIZI 600 mg/10 ml vials, valued at $12,239.38 with a firm fixed price structure. The delivery order is set to be completed by September 16, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGTHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of SKYRIZI 150 mg/ml pens with a ceiling value of $16,459.82. This firm fixed price delivery order, which completes on August 26, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical commodities to military healthcare programs worldwide. SKYRIZI is a biologic immunosuppressant used primarily for treating autoimmune and inflammatory conditions. This delivery order reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen demonstrates capability to fulfill federal medical supply requirements through competitive procurement processes, supporting the DLA's objective to maintain reliable supply chains for specialized medications across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 8/25/25 |